Study guide
12.3 Site Staffing, Training, and Documentation
Certified Clinical Research Coordinator CCRC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Scientific Concepts and Research Design
1.1 Protocol Elements 1.2 Study Design and Objectives 1.3 Study Endpoints and Biostatistics
2 Chapter 2: Ethical Principles and Guidelines
2.1 Ethical Principles (Declaration of Helsinki, Belmont Report) 2.2 Informed Consent Process and Documentation 2.3 Vulnerable Populations and Assent
3 Chapter 3: IRB/IEC Oversight and Participant Safety
3.1 IRB/IEC Functions and Oversight 3.2 Adverse Event Classification and Reporting 3.3 Safety Monitoring and Safety Reporting
4 Chapter 4: Participant Rights and Ethics
4.1 Participant Rights and Confidentiality (HIPAA/GDPR) 4.2 Conflicts of Interest 4.3 Ethical Scenarios in Clinical Trials
5 Chapter 5: Product Development and Regulatory Framework
5.1 Drug and Device Development Phases 5.2 U.S. and International Regulatory Frameworks 5.3 Investigational Product Investigator's Brochure (IB)
6 Chapter 6: Investigational Product Accountability
6.1 Investigational Product Labeling and Storage 6.2 Investigational Product Receipt, Dispensing, and Accountability 6.3 Investigational Product Return and Destruction
7 Chapter 7: Regulatory Submissions and Actions
7.1 Regulatory Submissions (IND, NDA, IDE, PMA) 7.2 Regulatory Actions and Compliance 7.3 Pharmacokinetics and Pharmacodynamics in Product Development
8 Chapter 8: Clinical Trial Operations and GCP Principles
8.1 Introduction to ICH E6 GCP Principles (including R3 updates) 8.2 Investigator Responsibilities under GCP 8.3 Sponsor Responsibilities and Oversight
9 Chapter 9: Essential Documents and Site Qualification
9.1 Essential Documents (Pre-study, During, Post-study) 9.2 Site Selection and Qualification 9.3 Quality Management and Standard Operating Procedures (SOPs)
10 Chapter 10: Protocol Deviations and Amendments
10.1 Protocol Adherence and Compliance 10.2 Protocol Deviations and Violations 10.3 Protocol Amendments and Version Control
11 Chapter 11: Monitoring Visits and Audits
11.1 Monitoring Preparation and Visit Types 11.2 Monitoring Visits (SIV, IMV, COV) 11.3 Regulatory Inspections and Site Audits
12 Chapter 12: Study and Site Management - Startup
12.1 Site Startup Operations 12.2 Site Budget and Contract Management 12.3 Site Staffing, Training, and Documentation
13 Chapter 13: Enrollment and Recruitment
13.1 Enrollment Management and Strategies 13.2 Participant Recruitment and Retention 13.3 Participant Compensation and Ethics
14 Chapter 14: Daily Trial Coordination
14.1 Visit Scheduling and Logistics 14.2 Equipment Maintenance and Calibration 14.3 Specimen Handling and Shipping (IATA/dangerous goods)
15 Chapter 15: Quality Improvement and Site Closeout
15.1 Participant Safety Management 15.2 Quality Improvement and Site Audits Preparation 15.3 Study and Site Closeout Procedures
16 Chapter 16: Source Documentation and Case Report Forms
16.1 Source Documentation Standards (ALCOA-C) 16.2 Case Report Forms and eCRF Completion 16.3 Electronic Data Capture (EDC) Systems
17 Chapter 17: Data Management and Queries
17.1 Data Management Processes 17.2 Data Queries and Discrepancy Resolution 17.3 Data Correction and Audit Trails
18 Chapter 18: Data Privacy and Records Retention
18.1 Data Privacy and Confidentiality 18.2 Records Retention and Archiving 18.3 Compliance in Clinical Trial Informatics
12.3 Site Staffing, Training, and Documentation
Key Takeaways Explain This Topic AI
The Delegation of Authority (DOA) log is the official record of qualified staff authorized by the PI to perform specific trial tasks.
Staff must be qualified and adequately informed about the protocol, the investigational product and their delegated activities (often via an SIV) before performing them; sponsors and IRBs often also require GCP and human-subject-protection training.
The PI can delegate tasks but retains ultimate responsibility for the conduct of the trial at the site.
Creating comprehensive source document templates during startup ensures protocol compliance and aids in accurate data collection during subject visits.
Last updated: October 2026
Introduction to Site Staffing and Training
A clinical trial is only as strong as the team executing it. Proper staffing, rigorous training, and meticulous documentation are foundational to GCP compliance and the ultimate success of the trial. During the startup phase, the site must assemble the right personnel, clearly define their responsibilities, ensure they are thoroughly trained on the protocol, and prepare the documents that will guide the daily conduct of the study.
Site Roles and Responsibilities
While the Principal Investigator (PI) holds ultimate responsibility for the conduct of the trial at the site, they rely heavily on a delegated team of professionals.
The Research Team
Principal Investigator (PI): The primary physician responsible for the medical care of the subjects and the overall integrity of the trial at the site. The PI must ensure GCP compliance and personally oversee the study.
Sub-Investigator (Sub-I): Additional physicians or qualified practitioners (like Nurse Practitioners or Physician Assistants) delegated by the PI to perform critical trial-related medical decisions and assessments.
Clinical Research Coordinator (CRC): The operational backbone of the trial. The CRC manages day-to-day activities, schedules subject visits, performs non-medical assessments, enters data, and acts as the primary liaison between the site, the sponsor, and the IRB.
Regulatory Coordinator: At larger sites, this specialized role handles all IRB submissions, essential document collection, and maintains the Investigator Site File (ISF) or Regulatory Binder.
Data Manager/Data Entry Coordinator: Responsible for entering data from source documents into the Electronic Data Capture (EDC) system and resolving data queries.
Investigational Drug Service (IDS) Pharmacist: Manages the receipt, storage, preparation, dispensing, and accountability of the investigational product.
The Delegation of Authority (DOA) Log
Under Good Clinical Practice (GCP), the PI is allowed to delegate tasks, but they cannot delegate responsibility. The Delegation of Authority (DOA) Log (sometimes called the Site Signature Log) is the official record of who is authorized to perform specific tasks.
Key Rules for the DOA Log:
Qualification: Personnel must be properly qualified by education, training, and experience to perform their delegated tasks. For example, only a licensed medical professional can be delegated to perform physical exams or assess adverse events.
Prior Delegation: Trial-specific tasks are delegated, and the delegation recorded, before the staff member performs them. Under ICH E6(R3) 2.3.3 the record is proportionate to the significance of the activity, and activities performed as part of clinical practice may not need delegation documentation.
Signatures and Initials: Every staff member must provide their signature and initials on the log to serve as a handwriting sample, which is used to verify source document entries later.
Start and End Dates: The log must accurately reflect when a staff member joined the study and when they left or were removed.
Audit Insight: The DOA log is one of the first documents an FDA inspector or sponsor auditor will review. If a CRC drew blood or administered informed consent prior to the start date on the DOA log, it is a major compliance finding.
Training Requirements
Before a site can begin screening subjects, all delegated staff must complete and document their training.
GCP and HSP Training
Most sponsors and IRBs require proof of current training in Good Clinical Practice (GCP) and Human Subject Protection (HSP) . This is often fulfilled through standardized courses like CITI (Collaborative Institutional Training Initiative), with refresher training at intervals the sponsor or institution sets.
Protocol-Specific Training and the SIV
The Site Initiation Visit (SIV) is the official protocol training session conducted by the sponsor's Clinical Research Associate (CRA). During the SIV, the CRA trains the PI and site staff on:
The disease state and investigational product mechanism of action.
The detailed Schedule of Assessments (SoA).
Inclusion and exclusion criteria.
Safety reporting procedures (how to report Serious Adverse Events).
EDC data entry guidelines and pharmacy manual procedures.
Attendance at the SIV is documented via a training log. If a staff member cannot attend the SIV, they must review the presentation slides and sign a separate training log before they can perform any study tasks.
Protocol Amendments
When a protocol is amended (which happens frequently), all relevant staff must be trained on the new version of the protocol, and this training must be documented. Failing to document training on amendments is a common audit finding.
Documentation: Source Documents and SOPs
A core tenet of clinical research is: "If it wasn't documented, it didn't happen." The startup phase is the time to prepare the tools necessary for impeccable documentation.
Creating Source Document Templates
Source documents are the original records where data is first recorded. While some sites use electronic health records (EHR) directly, many CRCs create custom source document templates (worksheets) tailored specifically to the protocol's Schedule of Assessments.
Well-designed source templates are critical for success because they:
Serve as a checklist for the CRC during a busy subject visit, ensuring no protocol-required procedures (like a specific vital sign or questionnaire) are missed.
Standardize the way data is collected across different staff members.
Make it significantly easier for the CRA to verify data during monitoring visits.
Best Practice: During startup, the CRC should draft source templates and compare them line-by-line against the protocol and the EDC data entry screens to ensure every data point required by the sponsor is captured on the worksheet.
Standard Operating Procedures (SOPs)
Sites should have internal Standard Operating Procedures (SOPs) that dictate how research is conducted at their facility. While not protocol-specific, SOPs ensure consistency and quality. Key SOPs to have in place during startup include:
- Obtaining Informed Consent
- Reporting Adverse Events
- Storing and Maintaining Essential Documents
- Equipment Calibration and Maintenance
- Handling and Shipping Biological Specimens
By establishing strong staffing structures, ensuring documented training, and preparing robust source documents, the CRC sets the stage for a compliant, high-enrolling, and successful clinical trial.